Interestingly, we did not observe any impact of impaired ACSL4-dependent ferroptosis on HCC formation in our metabolic NASH-HCC model (STZ-HFD). This evidence concerns the gene ACSL4 and metabolic dysfunction-associated steatohepatitis.